Sublingual immunotherapy tablets for dust mite allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how sublingual immunotherapy tablets, which are placed under the tongue, affect the body's response to dust mite allergies in people with allergic rhinitis. The goal is to understand how these tablets might change the immune system and help improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have moderate to severe dust mite allergic rhinitis, confirmed by a positive skin prick test or specific IgE blood test.
- You must have chosen sublingual immunotherapy tablets as your treatment.
- You cannot have other nasal conditions like nasal papilloma or nasal tumors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying the bacteria in your nose and mouth during treatment with an allergy spray placed under your tongue. The goal is to understand how this treatment affects your allergy symptoms and your body's natural defenses.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.
This study tests a daily under-the-tongue tablet or drops to reduce allergy symptoms caused by house dust mites. If you have allergic rhinitis and are bothered by dust mites, this treatment might help your nose feel better without needing shots.
This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Hear when a new Rhinitis, Allergic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.